Texas OAG Reaches $42.7 Million Settlement over Alleged Medicaid Fraud

Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • The Texas OAG settled with six subsidiaries of Takeda Pharmaceutical Co. to resolve allegations that the companies committed Medicaid fraud in violation of the Texas Medicaid Fraud Prevention Act (TMFPA).
  • According to the AG’s office, the settlement addresses alleged TMFPA violations raised by a whistleblower in a qui tam lawsuit. The lawsuit alleged that the companies provided nursing and reimbursement services for certain drugs to Texas Medicaid providers, and paid clinical nurse educators to refer or recommend the ADHD medication Vyvanse to providers.
  • The companies will pay $42.7 million to settle the allegations.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Cozen O'Connor | Attorney Advertising

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide